Melanoma Recurrence in NSW
Report on Melanoma Recurrence in NSW: Assessment of the feasibility of measuring melanoma recurrence in the NSW Central Cancer Registry.
Recurrence is an important outcome indicator in the treatment of melanoma. Data on recurrence could provide melanoma clinicians with an understanding of the performance of melanoma care in NSW and the epidemiology of recurrence. It could also provide a basis for national and international benchmarking.
The 2008 report Melanoma Recurrence in NSW contains the methods and results of a study designed to assess the feasibility of measuring the recurrence of melanoma in the NSW Central Cancer Registry (NSWCCR). The study was conducted in three distinct phases. The first was a cross-validation of known recurrences from the Sydney Melanoma Unit (SMU) with notifications to the NSWCCR. Next, a protocol was developed for measuring the recurrence of melanoma in the registry based on the findings from the cross- validation. Finally, the protocol was tested with a pilot measurement of recurrence for a random sample of 300 patients from the registry who were diagnosed with primary invasive melanoma in 2001.